T1	intervention 71 80	letrozole
T2	No-of-participants 503 506	956
T3	duration 264 271	5 years
T4	duration 605 614	24 months
T5	outcome-Measure 814 848	change in hot flushes at 12 months
T6	outcome 860 901	no difference in hot flushes at 12 months
T7	outcome 1049 1167	less worsening in vaginal problems, musculoskeletal pain, sleep disturbance, physical well-being and mood at 12 months
T8	outcome 1208 1267	clinically relevant worsening in key symptoms and global Qo
